Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,148.42
(
0.00%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 138058

Monday, 03/05/2012 10:37:32 AM

Monday, March 05, 2012 10:37:32 AM

Post# of 257580
Re: Orencia SC

http://finance.yahoo.com/news/orencia-sc-seems-growing-orencia-150400380.html

…three months post-launch, finds a steady adoption of the product among surveyed rheumatologists. Just over half of rheumatologists have initiated trial on Orencia SC (abatacept) for a cohort of their patients, (up from 42% one month post-launch)… there is a little cannibalization of share from the Orencia IV formulation…

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today